Skip to content

Envoy Medical COCH Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$234K+10.4%$241K+7.1%$208K-25.2%$222K-26.5%$212K-28.6%
$961K+17.9%$874K+17.8%$820K+0.1%$804K-2.1%$815K+10.4%
-$727K-20.6%-$633K-22.4%-$612K-13.1%-$582K-12.1%-$603K-36.7%
-310.7%-26.2pp-262.7%-32.9pp-294.2%-99.6pp-262.2%-90.3pp-284.4%-136pp
$13.38M+26.6%$12.49M+22.7%$10.4M-3.3%$10.46M+6.1%$10.57M+12.2%
$1.03M-41.9%$1.22M-29.6%$1.64M-5.0%$1.63M-5.9%$1.77M+9.1%
$7.99M+22.1%$7.93M+16.2%$7.78M-7.4%$7.02M-9.2%$6.54M-18.1%
$23.36M+18.6%$22.51M+15.5%$20.64M-4.9%$19.92M-1.1%$19.69M-0.4%
-$23.12M-18.7%-$22.27M-15.6%-$20.43M+4.7%-$19.7M+0.7%-$19.48M0.0%
-9,881.2%-693pp-9,240.7%-682pp-9,824%-2,115pp-8,873%-2,302pp-9,188.7%-2,632pp
$1.59M+94.9%$1.97M$1.77M$1.28M
$13K+130%-$1.49M+3.4%-$1.35M-$1.57M-$43K
-$23.11M-18.4%-$23.76M-14.2%-$21.79M-3.4%-$21.27M-57.0%-$19.52M+14.9%
-9,875.6%-667pp-9,857.3%-615pp-10,475%-2,895pp-9,579.3%-5,093pp-9,209%-1,485pp
-$1.01+26.3%-$1.22+18.1%-$1.36-16.2%-$1.40-115%-$1.37+18.0%
-$22.81M-18.3%-$21.97M-15.1%-$20.16M+5.1%-$19.46M+1.2%-$19.28M+0.3%
-9,747%-653pp-9,115.4%-634pp-9,694.2%-2,047pp-8,763.5%-2,243pp-9,094.3%-2,585pp
-$23.12M-18.7%-$22.27M-15.6%-$20.43M+4.7%-$19.7M+0.7%-$19.48M0.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Envoy Medical's revenue?
Envoy Medical (COCH) generated $234.0K in revenue over the trailing twelve months, up 10.4% year over year.
Is Envoy Medical profitable?
Envoy Medical is not currently profitable: it reported a net loss of $23.1M over the trailing twelve months, a -9875.6% net margin.
What are Envoy Medical's profit margins?
Gross margin is -310.7% and operating margin is -9881.2%, with a -9875.6% net margin.
What is Envoy Medical's earnings per share?
Envoy Medical's diluted EPS over the trailing twelve months is $-1.01.
Where does Envoy Medical's income statement data come from?
Every line is extracted from Envoy Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.